1. In Vitro and in Vivo Evaluation of Dosage Forms. USP 23 chapter <1088>, United States Pharmacopeial Convention, Inc., 1995, pp. 1927-1929.
2. J.P. Skelly, et al. Workshop Report. Scaleup of oral extended-release dosage forms. Pharm. Res. 10: 1800–1805(1993).
3. V.F. Smolen and R.J. Erb. Predictive conversion of in vitro dissolution data into in vivo drug response versus time profiles exemplified for plasma levels of warfarin. J. Pharm. Sci. 66: 297–304 (1977).
4. F. Langenbucher. Numerical convolution/deconvolution as a tool for correlating in vitro with in vivo drug availability. Pharm. Ind. 44: 1166–1172 (1982).
5. D.Z. D’Argenio and A. Schumitzky. ADAPT II User’s Guide. Biomedical Simulations Resource, University of Southern California, Los Angeles, 1992.